Cytokinetics Inc (CYTK)
47.66
-2.20
(-4.41%)
USD |
NASDAQ |
Nov 21, 16:00
47.86
+0.20
(+0.42%)
After-Hours: 20:00
Cytokinetics Enterprise Value: 5.529B for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.529B |
| November 19, 2024 | 5.674B |
| November 18, 2024 | 5.774B |
| November 15, 2024 | 5.571B |
| November 14, 2024 | 6.100B |
| November 13, 2024 | 6.248B |
| November 12, 2024 | 6.276B |
| November 11, 2024 | 6.562B |
| November 08, 2024 | 6.487B |
| November 07, 2024 | 6.234B |
| November 06, 2024 | 6.194B |
| November 05, 2024 | 5.842B |
| November 04, 2024 | 5.713B |
| November 01, 2024 | 5.753B |
| October 31, 2024 | 5.657B |
| October 30, 2024 | 5.693B |
| October 29, 2024 | 5.717B |
| October 28, 2024 | 5.805B |
| October 25, 2024 | 5.694B |
| October 24, 2024 | 5.822B |
| October 23, 2024 | 5.897B |
| October 22, 2024 | 6.121B |
| October 21, 2024 | 5.988B |
| October 18, 2024 | 6.125B |
| October 17, 2024 | 6.073B |
| Date | Value |
|---|---|
| October 16, 2024 | 6.161B |
| October 15, 2024 | 6.173B |
| October 14, 2024 | 6.069B |
| October 11, 2024 | 6.114B |
| October 10, 2024 | 5.910B |
| October 09, 2024 | 6.057B |
| October 08, 2024 | 6.049B |
| October 07, 2024 | 6.184B |
| October 04, 2024 | 6.326B |
| October 03, 2024 | 6.212B |
| October 02, 2024 | 5.846B |
| October 01, 2024 | 5.845B |
| September 30, 2024 | 5.869B |
| September 27, 2024 | 5.756B |
| September 26, 2024 | 5.791B |
| September 25, 2024 | 5.796B |
| September 24, 2024 | 5.794B |
| September 23, 2024 | 5.727B |
| September 20, 2024 | 5.925B |
| September 19, 2024 | 6.140B |
| September 18, 2024 | 6.180B |
| September 17, 2024 | 6.206B |
| September 16, 2024 | 6.275B |
| September 13, 2024 | 6.173B |
| September 12, 2024 | 5.959B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
424.34M
Minimum
Mar 18 2020
10.99B
Maximum
Jan 08 2024
3.197B
Average
3.043B
Median
Enterprise Value Benchmarks
| Ocugen Inc | 231.77M |
| Scholar Rock Holding Corp | 2.519B |
| Mirum Pharmaceuticals Inc | 2.121B |
| NeuroBo Pharmaceuticals Inc | -0.9906M |
| Edgewise Therapeutics Inc | 2.533B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -160.54M |
| Revenue (Quarterly) | 0.463M |
| Total Expenses (Quarterly) | 141.26M |
| EPS Diluted (Quarterly) | -1.36 |
| Gross Profit Margin (Quarterly) | -18.17K% |
| Profit Margin (Quarterly) | -34.67K% |
| Earnings Yield | -11.29% |
| Normalized Earnings Yield | -11.29 |